Community post

The business combination transaction between AmpliPhi and C3J, two phage therapy biotech companies, is expected to close today. The new name of the combined company will be Armata Pharmaceuticals, Inc., and shares will be expected to start trading on the New York Stock Exchange under the symbol “ARMP” tomorrow.